QLGN - Qualigen Therapeutics announces $12M direct offering stock -8%

Qualigen Therapeutics ([[QLGN]] -8.4%) has entered into a definitive agreement with a single institutional investor for $12M direct offering, expected to close on Dec. 18, 2020.It includes sale and purchase of: (i) 2,370,786 Qualigen's common shares, (ii) 1,000,000 pre-funded warrants (iii) 1,348,314 common warrants exercisable immediately and (iv) 842,696  common warrants exercisable six months after issuance at a combined purchase price of $3.56/share in a registered direct offering.Previously: Qualigen nabs additional U.S. patent for ALAN anticancer platform (Dec. 15)

For further details see:

Qualigen Therapeutics announces $12M direct offering, stock -8%